The share of corresponding/leading authors in scientific publications in endocrinology, diabetes, and metabolism in China is projected to rise consistently from 99.06% in 2024 to 99.9% in 2028, showing a clear trend of consolidation. This indicates an increasing control by a limited number of prominent Chinese researchers in publishing within these fields. In 2023, this share was a bit lower, reflecting a strengthening dominance over time.

Future trends to watch for include:

Potential impacts of policy changes on research funding and collaboration.
The influence of international collaborations and partnerships on publication shares.
Technological advancements that might democratize the publication process, thereby affecting lead author dynamics.